Überhöhte Arzneimittelbestände im Krankenhausapothekenlager
Definition
An Australian cardiology hospital using traditional imprest and inventory practices found its pharmacy stockholding at AUD 539,662. After applying a lean, value‑stream‑mapping approach to medicines management and imprest supply, stockholdings were reduced by 51% to AUD 275,406, with no reported detriment to care.[4][7] This demonstrates that pre‑improvement processes carried roughly AUD 264,000 of avoidable inventory on a single 180‑bed site. Extrapolated across similar hospitals, manual, non‑optimised inventory systems cause substantial over‑stocking, higher cost of capital, insurance and storage, and greater risk of obsolescence and expiry.
Key Findings
- Financial Impact: Quantified: In the cited 180‑bed hospital, avoidable inventory holding was ~AUD 264,256 (51% reduction from AUD 539,662 to AUD 275,406). Logic‑based range for comparable Australian hospitals: AUD 200,000–300,000 tied‑up working capital per hospital, plus 5–10% of that value annually in implicit holding and expiry costs.
- Frequency: Kontinuierlich; betrifft den gesamten Arzneimittelbestand in allen Stationen und der Zentralapotheke, mit täglichem Lagerhaltungsaufwand.
- Root Cause: Fehlende datengestützte Prognosen, keine standardisierten Lean‑Prozesse im Arzneimittelimprest, papierbasierte oder fragmentierte Systeme, begrenzte Transparenz über reale Verbrauchsdaten und Sicherheitsbestände.
Why This Matters
The Pitch: Hospitals in Australia 🇦🇺 waste AUD 250k–500k pro Jahr je Einrichtung durch überhöhte Arzneimittelbestände und Lagerhaltungskosten. Automation and lean inventory optimisation of pharmacy stock levels can cut holding costs by ~50% and free up hundreds of thousands of AUD in working capital.
Affected Stakeholders
Leitende Krankenhausapotheker:innen, Einkaufs- und Supply‑Chain‑Manager:innen, CFO / Finanzdirektor:innen, Stationsleitungen, Qualitäts- und Stewardship‑Beauftragte
Deep Analysis (Premium)
Financial Impact
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Current Workarounds
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Get Solutions for This Problem
Full report with actionable solutions
- Solutions for this specific pain
- Solutions for all 15 industry pains
- Where to find first clients
- Pricing & launch costs
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
Medikamentenverfall und Verschwendung durch ungenaue Lagerbestände
Verlorene Apotheker- und Pflegezeit durch manuelle Bestandsprozesse
Sanktions- und Auditrisiken durch unzureichende Arzneimittel- und Blutproduktdokumentation
Missed Charity Care Write-Offs
Charity Care Policy Non-Compliance Fines
Delayed Collections from Eligibility Delays
Request Deep Analysis
🇦🇺 Be first to access this market's intelligence